METACEL PHARMACEUTICALS LLC

Federal Circuit Rules Optional Storage Instructions Don't Induce Patent Infringement in Generic Drug Case

- The Federal Circuit affirmed that Rubicon's generic baclofen label does not induce patent infringement because it only optionally permits refrigerated storage while clearly instructing room temperature storage. - The court distinguished between drug labels that require infringing use versus those that merely permit it as an option, with only the former constituting induced infringement. - The ruling establishes that optional instruction language in drug labels, even if covered by a patent, may not result in induced infringement liability for generic manufacturers. - Brand companies are advised to seek FDA labeling that requires specific instructions rather than merely presenting options to maintain patent protection against generic competition.